ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors


Posted in: Drug Trial News | Medical Condition News

Tags: Abdominal Pain, Acute Lymphoblastic Leukemia, Anemia, Arthralgia, Atrial Fibrillation, Blindness, Blood, Blood Pressure, Brain, Cancer, Cell, Cholecystectomy, Chromosome, Chronic Myeloid Leukemia, Constipation, CT, Diabetes, Drugs, Dry Eye, Edema, Exon, Fatigue, Fistula, Glaucoma, Headache, Heart Failure, Heart Rate, Hyperlipidemia, Hypertension, Iritis, Keratitis, Kinase Inhibitor, Leukemia, Leukopenia, Lung Cancer, Lymphopenia, Macular Edema, Myeloid Leukemia, Nausea, Neuropathy, Neutropenia, Oncology, Pacemaker, Pain, Pancreatitis, Peripheral Edema, Peripheral Neuropathy, Pneumonia, Pregnancy, Regorafenib, Stenosis, Stroke, Sunitinib, Thrombocytopenia, Thrombosis, Tumor, Tyrosine, Vomiting, Wound Healing